SCHEMBL23881868

SCHEMBL23881868

O=C(O)CCC(NC(=O)OCc1ccccc1)P(=O)(O)Cc1cccc2ccccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 6/20 0.52
▸ ECE1 P42892 6/20 0.52
▸ CASP1 P29466 6/20 0.52
▸ ACP3 P15309 1/20 0.46
▸ HDAC3 O15379 1/20 0.46
▸ HDAC4 P56524 1/20 0.46
▸ HDAC1 Q13547 1/20 0.46
▸ HDAC7 Q8WUI4 1/20 0.46
▸ HDAC2 Q92769 1/20 0.46
▸ HDAC10 Q969S8 1/20 0.46
▸ HDAC11 Q96DB2 1/20 0.46
▸ HDAC8 Q9BY41 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.46
▸ HDAC9 Q9UKV0 1/20 0.46
▸ HDAC5 Q9UQL6 1/20 0.46
▸ NCOR2 Q9Y618 1/20 0.46
▸ ACE2 Q9BYF1 1/20 0.45
▸ KLK8 O60259 1/20 0.44
▸ F2 P00734 1/20 0.44
▸ F10 P00742 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23881694 0.93 CASP1 (0.51) MMEECE1CASP1ACP3HDAC3
SCHEMBL23881825 0.90 CASP1 (0.51) MMEECE1CASP1HDAC3HDAC4
SCHEMBL28603333 0.88 CASP1 (0.48) MMEECE1CASP1ACP3HDAC1
SCHEMBL23881726 0.85 ECE1 (0.61) MMEECE1ACE2F2PLAU
SCHEMBL23881909 0.83 CASP1 (0.49) MMEECE1CASP1HDAC3HDAC4
SCHEMBL23881761 0.81 ECE1 (0.56) MMEECE1HDAC3HDAC4HDAC1
SCHEMBL23881906 0.79 MME (0.52) MMEECE1ACE2KLK8F2
SCHEMBL23881767 0.79 ECE1 (0.59) MMEECE1CASP1ACE2KLK8
SCHEMBL23881871 0.78 ACE2 (0.48) MMEECE1ACE2
SCHEMBL23881752 0.77 ACP3 (0.54) ACP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192907-B2 Aminopeptidase A inhibitors and pharmaceutical compositions comprising the same QUANTUM GENOMICS (FR) 2021-12-07 — — US disclosed
US-20210309678-A1 AMINOPEPTIDASE A INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME Institut National de la Santé et de la Recherche Médicale (FR) 2021-10-07 — — US disclosed
CN-113166182-A Aminopeptidase A inhibitor and pharmaceutical composition comprising the same 量子基因公司 2021-07-23 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192907-B2 Aminopeptidase A inhibitors and pharmaceutical compositions comprising the same ANPEP, DNPEP, ENPEP MME 15/4885ECE1 54/4885CASP1 2019/4885
US-20210309678-A1 AMINOPEPTIDASE A INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME ANPEP, DNPEP, ENPEP MME 15/4885ECE1 54/4885CASP1 2019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback